The submission was not rejected but returned. Among them, both Polymatech and Waaree are notable, as their revised DRHPs will offer investors greater clarity, particularly concerning the upcoming financials for FY 23-24. Consequently, the valuation will be contingent upon the forthcoming results, which are anticipated to reflect the impressive growth trajectory of the company.
| Subscribe To Our Free Newsletter |
